Month: September 2013

Afternoon Update on Plandai Biotech (PLPL)

Plandai Biotechnology, Inc. PLPL
We’re sending out an update on PLPL this afternoon following this morning’s report. After trading as low as .55, the stock made its way back to .67, registering a 22% intraday gain in the process, and is currently holding support above the 50DMA.
In addition to an opportunity for a tidy profit during early trading, PLPL provided the public with a new press release that you can check out below. It eludes to an intellectual property licensing agreement, under the terms of which the company should be able to increase the effectiveness of its botanical extracts by a significant margin.

SEATTLE, WA, September 3, 2013 – (ACCESSWIRE) – Plandai Biotechnology, Inc. (PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical, today announced that it has signed an exclusive agreement with North-West University in Potchefstroom, South Africa, that holds the patents and associated intellectual property associated with the entrapment of compounds in long-chain fatty acids-based nano- and micro-particles, known as Pheroid(R). Under the terms of the world license, Plandai has the exclusive right to use the Pheroid(R) technology with all Phytofare polyene-based extracts, which includes proprietary extracts of most botanical matter, for human and animal use. >>> FULL PR

Some links for those who may have missed this morning’s newsletter:
PLPL Report
PLPL Video Chart

Extended Watchlist:
RENU, IWEB, LTCHD, NOK

Plandai Biotechnology, Inc. | PLPL | Added to Watchlist

Plandai Biotechnology, Inc. PLPL

Good morning traders, we hope everyone had an enjoyable long weekend. We’re bringing a new stock into the mix this morning in the agricultural/biotechnology business. The company’s main holding consists of an 8000+ acre plantation located in Mpumalanga, South Africa (2000 acres of which are used for production of green tea), and a recent licensing and raw-material provision agreement has it aligned with Phyto Nutricare.

This partnership will facilitate the delivery of Phytofare™ branded botanical extracts and nutraceuticals to the international marketplace. Some of the highlights of the Phytofare line include:

  • Patented Formula – The products are a result of years of research into plant extracts.
  • Consist of extracts taken from LIVING plant material, setting Phytofare™ apart.
  • Improved integration into bloodstream, known as “bio-availability” (More on that below)
  • Contain Nano-Sized Particles for maximum cell permeability.
  • Unique Isomeric Properties (Isomers are particles with the same molecular properties as a given element, while having different chemical properties.)

Plandai, through Phytofare™, has a chance at making a real dent in the green tea extract market. Currently, even high-purity green tea extracts on today’s market have been tested and found to be lacking in bio-availability, that is only a small amount (≤10%) of the essential nutrients are absorbed into the system. However, in USDA tests, Phytofare extracts have demonstrated improved bio-availability levels to as much as 60-80% which obviously is a dramatic increase in potency.

This apparent leap forward in green tea extract technology should allow PLPL to make its mark on the cosmeceutical, health & wellness, as well as the food & beverage industries. After all, who among current green tea extract consumers wouldn’t want the benefit of the same products they’ve come to appreciate having exponentially increased effectiveness? For this reason, we’re anxious to include PLPL on our watchlists moving forward.

We’ve also prepared a video of the PLPL chart to point out some of the highlights:

Additionally, the good folks over at BARCHART.COM currently give PLPL a 72% Overall “Buy” Rating, Including a 100% Rating on Long-Term Indicators.

More Info @

http://www.plandaibiotech.com/